D. Guber

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

A. Achiron, S. Miron, U. Givon, 2021, Multiple Sclerosis Journal.

COVID-19 vaccination in patients with multiple sclerosis: Safety and humoral efficacy of the third booster dose

A. Achiron, S. Miron, U. Givon, 2022, Journal of the Neurological Sciences.

COVID-19 vaccination in patients with multiple sclerosis: What we have learnt by February 2021

A. Achiron, S. Miron, U. Givon, 2021, Multiple Sclerosis.

Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study

A. Achiron, U. Givon, G. Harari, 2021, Journal of Neuroimmunology.